Alex Y.C. Huang, MD, PhD

Department of Pediatrics
School of Medicine
Department of Pathology
School of Medicine
Immune Oncology Program
Case Comprehensive Cancer Center
Medical Scientist Training Program
School of Medicine

In 2006, Dr. Huang joined the Case Western Reserve University School of Medicine faculty as an Assistant Professor in the Division of Pediatric Hematology / Oncology at Rainbow Babies & Children’s Hospital - Rainbow / Seidman Cancer Center with a secondary faculty appointment in the Department of Pathology, Biomedical Engineering and General Medical Sciences, as well as a member of the Case Comprehensive Cancer Center. Currently. Dr. Huang is also the director of clinical fellowship program in Pediatric Hematology / Oncology since 2007 and the director of CWRU's Medical Scientist Training Program. Dr. Huang was promoted to Associate Professor in 2012.

Research Information

Research Projects

Our laboratory is interested in applying this and other classical immunological techniques to study various aspects of anti-tumor immune responses, immune-host-pathogen interaction, T cell-mediated memory immunity, and chemokine - receptor biology.  

Ongoing projects include:

  1. Investigation into factors which influence the dynamic recruitment of T cells and their interactions with tumor cells and associated antigen-presenting cells in tumor-associated micro-environment.
  2. Imaging dynamic interaction between peri-vascular APC and T cells in the CNS during induction of acute experimental autoimmune encephalomyelitis.
  3. Discovering molecular signaling mechanisms responsible for the regulation of chemokine receptor expression on naive T cells.
  4. Testing the efficacy of genetically-modified tumor vaccines in the setting of sarcomas and other childhood cancer
  5. Developing imaging techniques to interrogate immune cell migration and interactions in tissues such as the bone marrow, lung, GI tract and the skin.
  6. Cellular and molecular mechanisms of metastasis in osteosarcoma, rhabdomyosarcoma and other common AYA and childhood cancer.  
  7. Mechanisms of immune checkpoint regulation in solid tumors.   
  8. Molecular mechanisms of T-cell Leukemogenesis and CNS metastasis.
  9. Exploring NK cell-based immunotherapy strategies against common pediatric and AYA cancers.

The long-term goal of our laboratory is to translate insights gained from basic investigations of in vivo immunity into rationally designed tumor vaccine and immunotherapeutic clinical trials, with a particular emphasis in the areas of pediatric sarcomas and other solid tumors in the pediatric and adolescent & young adult (AYA) populations.

External Appointments

Program Director, Pediatric Hematology and Oncology
University Hospitals Cleveland Medical Center
Director, Pediatric Hematology and Oncology Fellowship
University Hospitals Rainbow Babies & Children’s Hospital